Chunzhang Yang

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Topics

Reactive Oxygen Species

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Neuro-oncology advances

This page only lists publications with an associated author ORCID identifier.

Publications

Fengchao Lang, James A Cornwell, Karambir Kaur, Omar Elmogazy, Wei Zhang, Meili Zhang, Hua Song, Zhonghe Sun, Xiaolin Wu, Mirit I Aladjem, Michael Aregger, Steven D Cappell, Chunzhang Yang
Abrogation of the G2/M checkpoint as a chemosensitization approach for alkylating agents. Neuro-oncology 26 (6) (2024)
Fengchao Lang, James A Cornwell, Karambir Kaur, Omar Elmogazy, Wei Zhang, Meili Zhang, Hua Song, Zhonghe Sun, Xiaolin Wu, Mirit I Aladjem, Michael Aregger, Steven D Cappell, Chunzhang Yang
Abrogation of the G2/M checkpoint as a chemosensitization approach for alkylating agents. Neuro-oncology 26 (6) (2024)
Tuesday Haynes, Mark R Gilbert, Kevin Breen, Chunzhang Yang
Pathways to hypermutation in high-grade gliomas: Mechanisms, syndromes, and opportunities for immunotherapy. Neuro-oncology advances 6 (1) (2024)
Tuesday Haynes, Mark R Gilbert, Kevin Breen, Chunzhang Yang
Pathways to hypermutation in high-grade gliomas: Mechanisms, syndromes, and opportunities for immunotherapy. Neuro-oncology advances 6 (1) (2024)
Fengchao Lang, James A Cornwell, Karambir Kaur, Omar Elmogazy, Wei Zhang, Meili Zhang, Hua Song, Zhonghe Sun, Xiaolin Wu, Mirit I Aladjem, Michael Aregger, Steven D Cappell, Chunzhang Yang
Abrogation of the G2/M checkpoint as a chemosensitization approach for alkylating agents. Neuro-oncology 26 (6) (2024)
Fengchao Lang, James A Cornwell, Karambir Kaur, Omar Elmogazy, Wei Zhang, Meili Zhang, Hua Song, Zhonghe Sun, Xiaolin Wu, Mirit I Aladjem, Michael Aregger, Steven D Cappell, Chunzhang Yang
Abrogation of the G2/M checkpoint as a chemosensitization approach for alkylating agents. Neuro-oncology 26 (6) (2024)
Yang Liu, Fu-Ju Chou, Fengchao Lang, Meili Zhang, Hua Song, Wei Zhang, Dionne L Davis, Nicole J Briceno, Yang Zhang, Patrick J Cimino, Kareem A Zaghloul, Mark R Gilbert, Terri S Armstrong, Chunzhang Yang
Protein kinase B (PKB/AKT) protects IDH-mutated glioma from ferroptosis via Nrf2. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Fengchao Lang, James A Cornwell, Karambir Kaur, Omar Elmogazy, Wei Zhang, Meili Zhang, Hua Song, Zhonghe Sun, Xiaolin Wu, Mirit I Aladjem, Michael Aregger, Steven D Cappell, Chunzhang Yang
Abrogation of the G2/M checkpoint as a chemo sensitization approach for alkylating agents. Neuro-oncology (2023)
Prashant Chittaboina, Debjani Mandal, Alejandro Bugarini, David T Asuzu, Dustin Mullaney, Panagiotis Mastorakos, Stefan Stoica, Reinier Alvarez, Gretchen C Scott, Dragan Maric, Abdel G Elkahloun, Zhengping Zhuang, Emily Y Chew, Chunzhang Yang, W Marston Linehan, Russell R Lonser
Proteostasis modulation in germline missense von Hippel Lindau disease. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Fengchao Lang, James A Cornwell, Karambir Kaur, Omar Elmogazy, Wei Zhang, Meili Zhang, Hua Song, Zhonghe Sun, Xiaolin Wu, Mirit I Aladjem, Michael Aregger, Steven D Cappell, Chunzhang Yang
Abrogation of the G2/M checkpoint as a chemo sensitization approach for alkylating agents. Neuro-oncology (2023)
Yang Zhang, Yang Liu, Fengchao Lang, Chunzhang Yang
IDH mutation and cancer stem cell. Essays in biochemistry 66 (4) (2022)
Yang Liu, Chunzhang Yang
Oncometabolites in Cancer: Current Understanding and Challenges. Cancer research 81 (11) (2021)
Fu-Ju Chou, Yang Liu, Fengchao Lang, Chunzhang Yang
D-2-Hydroxyglutarate in Glioma Biology. Cells 10 (9) (2021)
Katerina Hadrava Vanova, Chunzhang Yang, Leah Meuter, Jiri Neuzil, Karel Pacak
Reactive Oxygen Species: A Promising Therapeutic Target for SDHx-Mutated Pheochromocytoma and Paraganglioma. Cancers 13 (15) (2021)
Yang Liu, Fengchao Lang, Fu-Ju Chou, Kareem A Zaghloul, Chunzhang Yang
Isocitrate Dehydrogenase Mutations in Glioma: Genetics, Biochemistry, and Clinical Indications. Biomedicines 8 (9) (2020)
Di Yu, Yang Liu, Yiqiang Zhou, Victor Ruiz-Rodado, Mioara Larion, Guo-Wang Xu, Chunzhang Yang
Triptolide suppresses IDH1-mutated malignancy via Nrf2-driven glutathione metabolism. Proceedings of the National Academy of Sciences of the United States of America 117 (18) (2020)
Yang Liu, Ying Pang, Boqun Zhu, Ondrej Uher, Veronika Caisova, Thanh-Truc Huynh, David Taieb, Katerina Hadrava Vanova, Hans Kumar Ghayee, Jiri Neuzil, Mark Levine, Chunzhang Yang, Karel Pacak
Therapeutic Targeting of SDHB-Mutated Pheochromocytoma/Paraganglioma with Pharmacologic Ascorbic Acid. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (14) (2020)
Xiaoying Tang, Xiao Fu, Yang Liu, Di Yu, Sabrina J Cai, Chunzhang Yang
Blockade of Glutathione Metabolism in IDH1-Mutated Glioma. Molecular cancer therapeutics 19 (1) (2019)
Sabrina J Cai, Yang Liu, Sue Han, Chunzhang Yang
Brusatol, an NRF2 inhibitor for future cancer therapeutic. Cell & bioscience 9 (2019)
Xiaoyu Cao, Yanxin Lu, Yang Liu, Yiqiang Zhou, Hua Song, Wei Zhang, Dionne Davis, Jing Cui, Shuyu Hao, Jinkyu Jung, Qixin Wu, Deric M Park, Chunzhang Yang
Combination of PARP inhibitor and temozolomide to suppress chordoma progression. Journal of molecular medicine (Berlin, Germany) 97 (8) (2019)
Ying Pang, Yang Liu, Karel Pacak, Chunzhang Yang
Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted Therapies. Cancers 11 (4) (2019)